Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine Augmentation of CBT for Agoraphobia
NCT01928823Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2011
- Primary completion
- May 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in agoraphobia, sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2011; status: completed.
02
Drugs
d-cycloserine
03
Conditions
agoraphobia
Beyond the preview
Go deeper on NCT01928823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928823.